Leslie, W. D. http://orcid.org/0000-0002-1056-1691
Morin, S.N.
Lix, L.M.
McCloskey, E.V.
Johansson, H.
Harvey, N.C.
Kanis, J.A.
Article History
Received: 12 April 2020
Accepted: 7 July 2020
First Online: 18 August 2020
Compliance with ethical standards
:
: Suzanne Morin: Nothing to declare for the context of this paper, but has received research grants, Amgen.Eugene McCloskey: Nothing to declare for the context of this paper, but numerous ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS, and Warner-Chilcott.Nicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, UCB, MSD, Eli Lilly, Kyowa Kirin, Radius Health, Servier, Shire, Consilient Healthcare, and Internis Pharma.John A. Kanis: Grants from Amgen, Lilly, Radius Health, and non-financial support from Medimaps outside the submitted work.William Leslie, Lisa Lix, Helena Johansson: No conflicts of interest.
: The study was approved by the Health Research Ethics Board for the University of Manitoba.